Boston Scientific Offers World Class Endoscopy Training at its Paris Institute for Advancing Science
Boston Scientific Offers World Class Endoscopy Training at its Paris Institute for Advancing Science
PR56764
PARIS, May 15 / PRN=KYODO JBN / --
- Boston Scientific Reinforces Its Commitment to Global Education and
Innovation
Boston Scientific Corporation (NYSE:BSX) celebrated the opening of a new
facility dedicated to endoscopy training within its Institute for Advancing
Science in Paris. The ceremony included major representatives of the endoscopy
medical community in Europe. Endoscopy professional training and education is
now part of the multi-disciplinary programs available for European physicians
within the Paris Institute.
The Institute is fully equipped with state-of-the-art technology to support
integrated hands-on and didactic medical training in endoscopy. It has a broad
range of endoscopes, bronchoscopes, advanced visualization systems and numerous
biological and non-biological models to recreate and simulate adapted clinical
conditions for training and education. Physicians will have access to a
complete endoscopy lab fully equipped with fluoroscopy capabilities and
simultaneous translation facilities. Boston Scientific offers a broad
curriculum of training courses from basic to advanced levels in a range of
specialties and techniques including Endoscopic Retrograde
Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS), cholangioscopy
and Bronchial Thermoplasty (BT). The Institute in Paris reinforces the
commitment that Boston Scientific has to innovation and education by offering
world class training facilities designed to meet the educational needs of
endoscopists, endosonographers and pulmonologists.
Over the last year, Boston Scientific trained more than 25,000 health care
providers worldwide through local and regional programs, seminars,
preceptorships and proctorships. In Europe alone, more than 2,500 nurses and
technicians participated in more than 300 training sessions in more than 12
countries as a part of the Boston Scientific Professional Development Program.
The company also unveiled several new centers of excellence. Last April, Boston
Scientific hosted physicians and fellows at its third Center of Excellence
Workshop at the National University Hospital in Singapore. Earlier this year,
the company launched the Endoscopy Institute in Shanghai, China, which provides
basic through advanced ERCP courses and fellowship training as well as a "train
the trainer" program. In March 2014, seven experts in ERCP participated in the
Institute's first faculty meeting and the first course took place in May. Most
recently, Boston Scientific opened a training center at its Endoscopy
headquarters in Marlborough, Massachusetts, including state-of-the-art
equipment to facilitate education and collaboration with health care providers.
In 2012, Boston Scientific became the first industry partner to commit to the
American Society for Gastrointestinal Endoscopy's (ASGE) capital campaign at
the Cornerstone Level for its global Institute for Training and Technology.
"The development of endoscopy training demonstrates Boston Scientific's
continued commitment to providing industry-leading training and education in
partnership with physicians and societies to further the practice of
endoscopy," said Paraic Curtis, vice president of Endoscopy Europe Boston
Scientific. "Hands-on training and peer-to-peer education are essential to
maintaining good clinical practice and improving the quality of patient care.
We hope that endoscopy training at the Institute for Advancing Science will
become an integral part of the training continuum of endoscopists and
pulmonologists across Europe."
To learn more about gastrointestinal products and procedures, please visit
http://www.bostonscientific.com/endo-resources.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions
that improve the health of patients around the world. As a global medical
technology leader for more than 30 years, we advance science for life by
providing a broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more information, visit
http://www.bostonscientific.com and connect on Twitter
[http://twitter.com/bostonsci ] and Facebook
[http://www.facebook.com/bostonscientific ].
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Forward-looking statements may be identified by words
like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend"
and similar words. These forward-looking statements are based on our beliefs,
assumptions and estimates using information available to us at the time and are
not intended to be guarantees of future events or performance. These
forward-looking statements include, among other things, statements regarding
our business plans, professional education and training, product performance
and competitive offerings. If our underlying assumptions turn out to be
incorrect, or if certain risks or uncertainties materialize, actual results
could vary materially from the expectations and projections expressed or
implied by our forward-looking statements. These factors, in some cases, have
affected and in the future (together with other factors) could affect our
ability to implement our business strategy and may cause actual results to
differ materially from those contemplated by the statements expressed in this
press release. As a result, readers are cautioned not to place undue reliance
on any of our forward-looking statements.
Factors that may cause such differences include, among other things: future
economic, competitive, reimbursement and regulatory conditions; new product
introductions; demographic trends; intellectual property; litigation; financial
market conditions; and, future business decisions made by us and our
competitors. All of these factors are difficult or impossible to predict
accurately and many of them are beyond our control. For a further list and
description of these and other important risks and uncertainties that may
affect our future operations, see Part I, Item 1A - Risk Factors in our most
recent Annual Report on Form 10-K filed with the Securities and Exchange
Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly
Reports on Form 10-Q we have filed or will file hereafter. We disclaim any
intention or obligation to publicly update or revise any forward-looking
statements to reflect any change in our expectations or in events, conditions,
or circumstances on which those expectations may be based, or that may affect
the likelihood that actual results will differ from those contained in the
forward-looking statements. This cautionary statement is applicable to all
forward-looking statements contained in this document.
Source: Boston Scientific
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。